{"id":780898,"date":"2023-08-30T08:06:50","date_gmt":"2023-08-30T12:06:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/"},"modified":"2023-08-30T08:06:50","modified_gmt":"2023-08-30T12:06:50","slug":"amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/","title":{"rendered":"AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care"},"content":{"rendered":"

<\/p>\n

AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care<\/i><\/b><\/p>\n

New name of company reflects unified global presence and collective goal of creating healthier futures by accelerating positive outcomes for customers and their patients<\/i><\/p>\n

Company announces more than $5 million commitment to global corporate philanthropic efforts<\/i><\/p>\n

CONSHOHOCKEN, Pa.–(BUSINESS WIRE<\/a>)–
\nCencora, Inc. (NYSE: COR) today announced the completion of its name and stock ticker change from AmerisourceBergen Corporation (NYSE: ABC), marking the latest stage of the company\u2019s evolution as a leader in global pharmaceutical services. Cencora will begin trading under the new ticker symbol \u201cCOR\u201d on the New York Stock Exchange at the open of the market trading today, August 30, 2023.<\/p>\n

\nUnder the new name Cencora, the company unifies its 46,000 employees \u2013 across several global business segments \u2013 under one identity, propelled by a bold vision and purpose-driven approach to creating healthier futures.<\/p>\n

\nThe new name underscores Cencora\u2019s experience and vision when it comes to connecting manufacturers, providers, pharmacies and patients, and ensuring the consistent, reliable flow of treatments to those who need them at a time of growing complexity.<\/p>\n

\n“Today is a significant and exciting milestone for Cencora. Our new name is a reminder of our customers, their patients, and our team members who are at the center of everything we do,\u201d said Steven H. Collis, Chairman, President & Chief Executive Officer of Cencora. \u201cIt represents the healthier futures we strive for serving as a trusted industry partner that prioritizes innovation, advocates for patient access, and advances strategic partnerships across the global pharmaceutical value chain.\u201d<\/p>\n

\nAs a global healthcare company, Cencora will continue to invest in and focus on its core pharmaceutical distribution business, while also growing its platform of pharma and biopharma services to support pharmaceutical innovation and access across the globe.<\/p>\n

\nAligned with the company\u2019s purpose, and to commemorate this seminal moment in the organization\u2019s history, Cencora also announced a $5 million donation to the Cencora Impact Foundation, formerly known as the AmerisourceBergen Foundation, an independent not-for-profit charitable giving organization. The donation will be used to launch the Cencora Healthier Futures Grant Program, which aims to identify opportunities to support those on the front lines of healthcare in underserved populations who are driving innovation in global health. Targeted donations from the Cencora Healthier Futures Grant Program, operated by Cencora Impact Foundation, will go toward nonprofits and charities around the world that are advancing access to care and directly impacting communities in need.<\/p>\n

\nThe inaugural donation out of the Cencora Healthier Futures Grant Program will be a $500,000 grant made to the UNICEF Health Fund, which focuses on ensuring that every child has the ability to survive and thrive by providing strong primary healthcare systems, training healthcare professionals, and working closely with national governments to ensure programs are replicable at scale. These system-wide responses aim to reduce the number of maternal and newborn deaths, provide children with immunizations, reduce malnutrition, address adolescent mental health, and combat the rise of non-communicable diseases.<\/p>\n

\n\u201cWe are grateful for support from the Cencora Impact Foundation to help UNICEF deliver large-scale, sustainable results in ensuring the health of the world\u2019s most vulnerable children,\u201d said V. Ren\u00e9e Cutting, Chief Philanthropy Officer, UNICEF USA.<\/p>\n

\nCencora Ventures, formerly known as AB Health Ventures, the company\u2019s dedicated corporate venture fund, has also committed to donating 10% of future realized profits to support the efforts of the Cencora Impact Foundation and its continued work to improve healthcare access globally.<\/p>\n

\nFor more information about the rebrand and updated design and branding elements, visit: www.cencora.com<\/a><\/p>\n

About Cencora<\/b><\/p>\n

\nCencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures<\/i>. Cencora is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than $200 billion in annual revenue. Learn more at www.cencora.com<\/a><\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20230830469400\/en\/<\/a><\/span><\/p>\n

Media:
\n<\/b>
Lauren Esposito
\n
215-460-6981
\n
lesposito@amerisourcebergen.com
\n<\/a><\/p>\n

Investors:
\n<\/b>
Bennett S. Murphy
\n
610-727-3693
\n
bmurphy@amerisourcebergen.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America Pennsylvania<\/p>\n

INDUSTRY KEYWORDS:<\/b> General Health Philanthropy Pharmaceutical Other Communications Fund Raising Foundation Public Relations\/Investor Relations Marketing Veterinary Advertising Communications Other Philanthropy Health<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care New name of company reflects unified global presence and collective goal of creating healthier futures by accelerating positive outcomes for customers and their patients Company announces more than $5 million commitment to global corporate philanthropic efforts CONSHOHOCKEN, Pa.–(BUSINESS WIRE)– Cencora, Inc. (NYSE: COR) today announced the completion of its name and stock ticker change from AmerisourceBergen Corporation (NYSE: ABC), marking the latest stage of the company\u2019s evolution as a leader in global pharmaceutical services. Cencora will begin trading under the new ticker symbol \u201cCOR\u201d on the New York Stock Exchange at the open of the market trading today, August 30, 2023. … <\/p>\n

Continue reading “AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-780898","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care New name of company reflects unified global presence and collective goal of creating healthier futures by accelerating positive outcomes for customers and their patients Company announces more than $5 million commitment to global corporate philanthropic efforts CONSHOHOCKEN, Pa.–(BUSINESS WIRE)– Cencora, Inc. (NYSE: COR) today announced the completion of its name and stock ticker change from AmerisourceBergen Corporation (NYSE: ABC), marking the latest stage of the company\u2019s evolution as a leader in global pharmaceutical services. Cencora will begin trading under the new ticker symbol \u201cCOR\u201d on the New York Stock Exchange at the open of the market trading today, August 30, 2023. … Continue reading "AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-30T12:06:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230830469400r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care\",\"datePublished\":\"2023-08-30T12:06:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\\\/\"},\"wordCount\":783,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230830469400r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\\\/\",\"name\":\"AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230830469400r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2023-08-30T12:06:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230830469400r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230830469400r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/","og_locale":"en_US","og_type":"article","og_title":"AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care - Market Newsdesk","og_description":"AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care New name of company reflects unified global presence and collective goal of creating healthier futures by accelerating positive outcomes for customers and their patients Company announces more than $5 million commitment to global corporate philanthropic efforts CONSHOHOCKEN, Pa.–(BUSINESS WIRE)– Cencora, Inc. (NYSE: COR) today announced the completion of its name and stock ticker change from AmerisourceBergen Corporation (NYSE: ABC), marking the latest stage of the company\u2019s evolution as a leader in global pharmaceutical services. Cencora will begin trading under the new ticker symbol \u201cCOR\u201d on the New York Stock Exchange at the open of the market trading today, August 30, 2023. … Continue reading \"AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-30T12:06:50+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230830469400r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care","datePublished":"2023-08-30T12:06:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/"},"wordCount":783,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230830469400r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/","name":"AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230830469400r1&sid=flmnd&distro=nx&lang=en","datePublished":"2023-08-30T12:06:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230830469400r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230830469400r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amerisourcebergen-becomes-cencora-in-alignment-with-the-companys-growing-global-footprint-and-central-role-in-pharmaceutical-access-and-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AmerisourceBergen becomes Cencora, in alignment with the company\u2019s growing global footprint and central role in pharmaceutical access and care"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/780898","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=780898"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/780898\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=780898"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=780898"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=780898"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}